Back
PubMed

Cancer Spectrum and Gene-Specific Patterns in Lynch Syndrome: Insights From 47 Families in a Brazilian Institutional Cohort.

Bassaneze T, Oliveira Ferreira F, et al.JCO Glob Oncol 2026 · May 2026
Relevance score
6/10
Disease / domain
Lynch syndrome — gene-specific tumor spectrum (Brazilian cohort)
Source
PubMed
PMID 42160694
Share on LinkedIn

Gene / mechanism

Retrospective cohort of 47 Brazilian Lynch families (729 individuals, 78 confirmed carriers) — tumor spectrum and genotype-phenotype correlations by MMR gene

Summary

In a Brazilian institutional Lynch cohort of 47 families (2013–2019, 729 individuals, 78 confirmed carriers), carriers had higher cancer prevalence (64.1% vs 37.9% in untested relatives), younger age at first cancer (42.3 vs 47.3 years), and more multiple primaries. Colorectal cancer predominated across all genes; endometrial tumors were more frequent in MLH1/MSH2 and urothelial tumors in MSH2. The low testing rate (15.2% of relatives) argues for systematizing cascade testing.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

This Brazilian cohort confirms known Lynch patterns in an underrepresented population — essential for adapting recommendations to non-European contexts. The low testing rate of relatives (15.2%) illustrates the worldwide cascade testing challenge. Gene-specific data on urothelial tumors in MSH2 are consistent with the literature and reinforce urological surveillance in this subgroup.

Why this score?

Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Journal quality: 0/1 → Total: 6/10

Keywords

Lynch syndromeMMRtumor spectrumBrazilcascade testing
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime